Supplemental Figures 1-5, Tables 4-6 from Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer

Authors:
  • JYJi-Yeon Yang
    Ji-Yeon Yang
  • HWHenrica M.J. Werner
    Henrica M.J. Werner
  • JLJie Li
    Jie Li
  • SWShannon N. Westin
    Shannon N. Westin
  • YLYiling Lu
    Yiling Lu
  • MHMari K. Halle
    Mari K. Halle
  • JTJone Trovik
    Jone Trovik
  • HSHelga B. Salvesen
    Helga B. Salvesen
  • GMGordon B. Mills
    Gordon B. Mills
  • HLHan Liang
    Han Liang

Abstract
Supplemental Figures 1-5, Tables 4-6. Supplemental Figure 1. Kaplan-Meier curves comparing overall survivals for the training and validation cohorts Supplemental Figure 2. Kaplan-Meier curves for the late-stage EEC samples (FIGO 2009 stages III & IV) in the training and validation cohorts. Supplemental Figure 3. Plots in the first column display the distributions of risk scores of earlystage EEC samples in the training and validation cohorts. Supplemental Figure 4. Kaplan-Meier curves for the early-stage and late-stage EEC samples in the training and validation cohorts. Supplemental Figure 5. Kaplan-Meier curves for the late-stage EEC samples (stages III & IV) in the training and validation cohorts. Risk scores for patients were computed using the late-stage integrative model. Supplemental Table 4. Markers comprising the integrative model for the patients with early-stage EEC Supplemental Table 5. Markers included the integrative model for patients with late-stage EEC Supplemental Table 6. Univariate and multivariate Cox's proportional hazards model analysis for the late-stage EEC samples